Dutch breast cancer diagnosis delays "unacceptable"
This article was originally published in Clinica
44% of Dutch breast cancer patients have to wait longer than the national guidelines for diagnosis to be confirmed, and almost three quarters have to wait more than the prescribed four weeks for treatment to begin. So says a survey of 1,500 former breast cancer patients by the Dutch breast cancer association (BVN), published this week.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.